Single RP-HPLC method for simultaneous estimation of pioglitazone, glibenclamide and glibenclamide impurities from a combination drug product

A simple reversed phase HPLC method was developed for simultaneous estimation of pioglitazone, glibenclamide, and glibenclamide impurities A and B from a combination drug product. The drugs and impurities are well separated using a reverse phase liquid chromatography with C-8 column. The isocratic m...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Elango, Kuppanagounder Pitchaimuthu, Karunakaran, Kulandaivelu, Navaneethan, Gurusamy
Formato: Articulo Comunicacion
Lenguaje:Inglés
Publicado: 2011
Materias:
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/8351
http://www.latamjpharm.org/resumenes/30/8/LAJOP_30_8_2_3.pdf
Aporte de:
id I19-R120-10915-8351
record_format dspace
institution Universidad Nacional de La Plata
institution_str I-19
repository_str R-120
collection SEDICI (UNLP)
language Inglés
topic Farmacia
Combinación de Medicamentos
RP-HPLC; pioglitazone; glibenclamide; validation; impurities
Control de Calidad
Cromatografía Liquida
Estudios de Validación
spellingShingle Farmacia
Combinación de Medicamentos
RP-HPLC; pioglitazone; glibenclamide; validation; impurities
Control de Calidad
Cromatografía Liquida
Estudios de Validación
Elango, Kuppanagounder Pitchaimuthu
Karunakaran, Kulandaivelu
Navaneethan, Gurusamy
Single RP-HPLC method for simultaneous estimation of pioglitazone, glibenclamide and glibenclamide impurities from a combination drug product
topic_facet Farmacia
Combinación de Medicamentos
RP-HPLC; pioglitazone; glibenclamide; validation; impurities
Control de Calidad
Cromatografía Liquida
Estudios de Validación
description A simple reversed phase HPLC method was developed for simultaneous estimation of pioglitazone, glibenclamide, and glibenclamide impurities A and B from a combination drug product. The drugs and impurities are well separated using a reverse phase liquid chromatography with C-8 column. The isocratic mobile phase comprising phosphate buffer (pH 5.0): acetonitrile in the ratio of 75:25 (v/v) at 1.0 mL/min flow rate, UV detection at 250 nm, column temperature was maintained at 30 °C and the injection volume was used 150 μL. The proposed method was validated according to the ICH guidelines and proved suitable for routine analysis and quality control testing of these drugs in pharmaceutical preparations.
format Articulo
Comunicacion
author Elango, Kuppanagounder Pitchaimuthu
Karunakaran, Kulandaivelu
Navaneethan, Gurusamy
author_facet Elango, Kuppanagounder Pitchaimuthu
Karunakaran, Kulandaivelu
Navaneethan, Gurusamy
author_sort Elango, Kuppanagounder Pitchaimuthu
title Single RP-HPLC method for simultaneous estimation of pioglitazone, glibenclamide and glibenclamide impurities from a combination drug product
title_short Single RP-HPLC method for simultaneous estimation of pioglitazone, glibenclamide and glibenclamide impurities from a combination drug product
title_full Single RP-HPLC method for simultaneous estimation of pioglitazone, glibenclamide and glibenclamide impurities from a combination drug product
title_fullStr Single RP-HPLC method for simultaneous estimation of pioglitazone, glibenclamide and glibenclamide impurities from a combination drug product
title_full_unstemmed Single RP-HPLC method for simultaneous estimation of pioglitazone, glibenclamide and glibenclamide impurities from a combination drug product
title_sort single rp-hplc method for simultaneous estimation of pioglitazone, glibenclamide and glibenclamide impurities from a combination drug product
publishDate 2011
url http://sedici.unlp.edu.ar/handle/10915/8351
http://www.latamjpharm.org/resumenes/30/8/LAJOP_30_8_2_3.pdf
work_keys_str_mv AT elangokuppanagounderpitchaimuthu singlerphplcmethodforsimultaneousestimationofpioglitazoneglibenclamideandglibenclamideimpuritiesfromacombinationdrugproduct
AT karunakarankulandaivelu singlerphplcmethodforsimultaneousestimationofpioglitazoneglibenclamideandglibenclamideimpuritiesfromacombinationdrugproduct
AT navaneethangurusamy singlerphplcmethodforsimultaneousestimationofpioglitazoneglibenclamideandglibenclamideimpuritiesfromacombinationdrugproduct
bdutipo_str Repositorios
_version_ 1764820488684568579